Joseph F Kaminski

US Patent:

6561977, May 13, 2003

Filed:

Sep 27, 2001

Appl. No.:

09/965155

Inventors:

Bruce A. Williams - Flemington NJ
Joseph K. Kaminski - Hampton NJ

Assignee:

Celgene Corporation - Warren NJ

International Classification:

A61B 500

US Classification:

600300, 128920, 235375, 705 3, 702 19

Abstract:

Methods for delivering a drug to a patients in need of the drug, while restricting access to the drug by patients for whom the drug may be contraindicated are disclosed. The methods are of the type in which prescriptions for the drug are filled by a pharmacy only after a computer readable storage medium has been consulted to retrieve a prescription approval code. Embodiments are provided wherein the patients are assigned to risk groups based upon the risk that taking the drug will lead to an adverse side effect, and certain additional information, such as periodic surveys and diagnostic tests probative of the ongoing risk of the side effect developing are obtained before prescriptions for the drug are approved.

US Patent:

6755784, Jun 29, 2004

Filed:

Mar 7, 2003

Appl. No.:

10/383275

Inventors:

Bruce A. Williams - Flemington NJ
Joseph K. Kaminski - Hampton NJ

Assignee:

Celgene Corporation - Warren NJ

International Classification:

A61B 500

US Classification:

600300, 128920

Abstract:

Methods for delivering a drug to a patients in need of the drug, while restricting access to the drug by patients for whom the drug may be contraindicated are disclosed. The methods are of the type in which prescriptions for the drug are filled by a pharmacy only after a computer readable storage medium has been consulted to retrieve a prescription approval code. Embodiments are provided wherein the patients are assigned to risk groups based upon the risk that taking the drug will lead to an adverse side effect, and certain additional information, such as periodic surveys and diagnostic tests probative of the ongoing risk of the side effect developing are obtained before prescriptions for the drug are approved.

US Patent:

6869399, Mar 22, 2005

Filed:

Jan 22, 2004

Appl. No.:

10/762880

Inventors:

Bruce A. Williams - Flemington NJ, US
Joseph K. Kaminski - Hampton NJ, US

Assignee:

Celgene Corporation - Warren NJ

International Classification:

A61B005/00

US Classification:

600300, 128920

Abstract:

Methods for delivering a drug to a patients in need of the drug, while restricting access to the drug by patients for whom the drug may be contraindicated are disclosed. The methods are of the type in which prescriptions for the drug are filled by a pharmacy only after a computer readable storage medium has been consulted to retrieve a prescription approval code. Embodiments are provided wherein the patients are assigned to risk groups based upon the risk that taking the drug will lead to an adverse side effect, and certain additional information, such as periodic surveys and diagnostic tests probative of the ongoing risk of the side effect developing are obtained before prescriptions for the drug are approved.

US Patent:

7141018, Nov 28, 2006

Filed:

Jan 3, 2005

Appl. No.:

11/028144

Inventors:

Bruce A. Williams - Flemington NJ, US
Joseph K. Kaminski - Hampton NJ, US

Assignee:

Celgene Corporation - Summit NJ

International Classification:

A61B 5/00

US Classification:

600300, 128920, 705 2

Abstract:

Methods for delivering a drug to a patients in need of the drug, while restricting access to the drug by patients for whom the drug may be contraindicated are disclosed. The methods are of the type in which prescriptions for the drug are filled by a pharmacy only after a computer readable storage medium has been consulted to retrieve a prescription approval code. Embodiments are provided wherein the patients are assigned to risk groups based upon the risk that taking the drug will lead to an adverse side effect, and certain additional information, such as periodic surveys and diagnostic tests probative of the ongoing risk of the side effect developing are obtained before prescriptions for the drug are approved.

US Patent:

7959566, Jun 14, 2011

Filed:

May 19, 2006

Appl. No.:

11/437551

Inventors:

Bruce A. Williams - Flemington NJ, US
Joseph K. Kaminski - Hampton NJ, US

Assignee:

Celgene Corporation - Warren NJ

International Classification:

A61B 5/00

US Classification:

600300, 128920, 705 3, 235375

Abstract:

Methods for delivering a drug to a patients in need of the drug, while restricting access to the drug by patients for whom the drug may be contraindicated are disclosed. The methods are of the type in which prescriptions for the drug are filled by a pharmacy only after a computer readable storage medium has been consulted to retrieve a prescription approval code. Embodiments are provided wherein the patients are assigned to risk groups based upon the risk that taking the drug will lead to an adverse side effect, and certain additional information, such as periodic surveys and diagnostic tests probative of the ongoing risk of the side effect developing are obtained before prescriptions for the drug are approved.

US Patent:

8315886, Nov 20, 2012

Filed:

Dec 13, 2010

Appl. No.:

12/966261

Inventors:

Bruce A. Williams - Flemington NJ, US
Joseph K. Kaminski - Hampton NJ, US

Assignee:

Celgene Corporation - Warren NJ

International Classification:

G06Q 50/00

US Classification:

705 2

Abstract:

Methods for delivering a drug to a patients in need of the drug, while restricting access to the drug by patients for whom the drug may be contraindicated are disclosed. The methods are of the type in which prescriptions for the drug are filled by a pharmacy only after a computer readable storage medium has been consulted to retrieve a prescription approval code. Embodiments are provided wherein the patients are assigned to risk groups based upon the risk that taking the drug will lead to an adverse side effect, and certain additional information, such as periodic surveys and diagnostic tests probative of the ongoing risk of the side effect developing are obtained before prescriptions for the drug are approved.

US Patent:

8626531, Jan 7, 2014

Filed:

Aug 22, 2012

Appl. No.:

13/591622

Inventors:

Bruce A. Williams - Flemington NJ, US
Joseph K. Kaminski - Hampton NJ, US

Assignee:

Celgene Corporation - Summit NJ

International Classification:

G06Q 50/00

US Classification:

705 2

Abstract:

Methods for delivering a drug to a patients in need of the drug, while restricting access to the drug by patients for whom the drug may be contraindicated are disclosed. The methods are of the type in which prescriptions for the drug are filled by a pharmacy only after a computer readable storage medium has been consulted to retrieve a prescription approval code. Embodiments are provided wherein the patients are assigned to risk groups based upon the risk that taking the drug will lead to an adverse side effect, and certain additional information, such as periodic surveys and diagnostic tests probative of the ongoing risk of the side effect developing are obtained before prescriptions for the drug are approved.

US Patent:

20050276792, Dec 15, 2005

Filed:

Mar 22, 2005

Appl. No.:

11/088149

Inventors:

Joseph Kaminski - Lebanon NJ, US
Mark Deibert - Monroe Township NJ, US
Chris Goodman - Green Brook NJ, US
Barnett Feingold - New York NY, US

International Classification:

A61K045/00
G06F017/60
C12N005/08

US Classification:

424093700, 435372000, 705002000

Abstract:

Methods, computer systems, and computer program products for maintaining a stem cell registry comprising information about a plurality of stem cell units. A donor is enrolled in the stem cell registry. A stem cell unit from the donor is characterized. Information about the stem cell unit, obtained by the characterizing, is recorded in the stem cell registry. Computer readable media comprising a plurality of data records. One or more respective data records in the plurality of data records comprises (i) a collection identifier number that uniquely corresponds to a stem cell donation, (ii) a cord blood cell count associated with the stem cell donation, and (iii) a placenta blood cell count associated with the stem cell donation. Additional computer readable media comprising a plurality of data records. One or more respective data records in the plurality of data records comprises (i) a cord blood cell count associated with a stem cell donation, (ii) a placenta blood cell count associated with the stem cell donation, and (iii) an indication of at least two stem cell transplant units in the stem cell donation.